Nu rammer Trumps medicinkrig. Priserne skal op – ellers truer medicingiganter med at fravælge Danmark
Full story
Pharmaceutical companies may stop selling products in Denmark due to new lists from the Trump administration. The industry's trade organization warns that prices must increase to prevent this outcome. If the market becomes unattractive, patients might not get access to new medicines. An expert believes this risk is real. However, the regions do not agree with this assessment.
Nye lister fra Trump-administrationen vil få medicinalgiganter til at fravælge det danske marked. Sådan lyder advarslen fra industriens brancheorganisation, som mener, at priserne skal op. Ellers risikerer patienter at se langt efter nye lægemidler. Ekspert kalder risikoen reel, men regionerne genkender ikke billedet.